Navigation Links
Drug can reverse overgrown hearts to help prevent heart failure, UT Southwestern researchers find
Date:5/30/2011

DALLAS May 31, 2011 A promising cancer treatment drug can restore function of a heart en route to failure from high blood pressure, researchers at UT Southwestern Medical Center have found.

The drug, a type of histone deacetylase (HDAC) inhibitor being evaluated in numerous ongoing clinical trials, has been shown to reverse the harmful effects of autophagy in heart muscle cells of mice. Autophagy is a natural process by which cells eat their own proteins to provide needed resources in times of stress. The new study appears in Proceedings of the National Academy of Sciences.

"This opens the way for a new therapeutic strategy in hypertensive heart disease, one we can test for potential to promote regression of heart disease," said Dr. Joseph Hill, chief of cardiology and director of the Harry S. Moss Heart Center at UT Southwestern.

Dr. Hill, senior author of the study, and other researchers have shown previously that all forms of heart disease involve either too much or too little autophagy, normally an adaptive process. For example, in the presence of high blood pressure, the heart enlarges, or hypertrophies, and autophagy is turned on. Ultimately, the hypertension-stressed heart can go into failure.

Prior research from Dr. Hill's laboratory has shown that HDAC inhibitors blunt disease-associated heart growth, so researchers designed this study to determine what impact a particular type of HDAC inhibitor had on autophagy.

The researchers engineered mice with overactive autophagy and induced hypertrophy leading to heart failure. Scientists then gave the mice an HDAC inhibitor known to limit autophagy.

"The heart decreased back to near its normal size, and heart function that had previously been declining went back to normal," Dr. Hill said. "That is a powerful observation where disease regression, not just disease prevention, was seen."

Dr. Hill noted that the research that led to this finding started decades ago and included studies led by Dr. Kern Wildenthal, former president of UT Southwestern and now president of Southwestern Medical Foundation.

"This is one of those exciting, but rare, examples where an important finding made originally in yeast moved into mouse models and is soon moving to humans," Dr. Hill said. "That's the Holy Grail for a physician-scientist to translate those sorts of fundamental molecular discoveries through preclinical studies and ultimately in humans."


'/>"/>

Contact: LaKisha Ladson
lakisha.ladson@utsouthwestern.edu
214-648-3404
UT Southwestern Medical Center
Source:Eurekalert

Related medicine news :

1. Treating Back Pain May Reverse Its Impact on Brain
2. Breakthrough medical food reverses risk of heart disease and diabetes
3. Heart damage improves, reverses after stem cell injections in a preliminary human trial
4. Gene Therapy May Help Reverse Parkinsons Symptoms
5. Placebo Effect May Work in Reverse
6. Scientists Find Way to Partially Reverse Aging in Mice
7. Rheumatoid arthritis signaling protein reverses Alzheimers disease in mouse model
8. 50+ and Fabulous: Three Non-Surgical Procedures Effectively Reverse the Signs of Aging
9. Vaccine Reverses Type 1 Diabetes in Mice
10. EVMS receives more than $1 million in federal funds to develop new ways to reverse type 1 diabetes
11. Screening Teens Hearts Could Be Lifesaving
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/24/2017)... ... January 24, 2017 , ... “Mysteries Revealed On Speaking In ... mysterious phenomenon is available to all Christians. “Mysteries Revealed On Speaking In Tongues” is ... Beautiful Creation,” a Christian-based talk show located in Michigan. , “We need to ...
(Date:1/24/2017)... PA (PRWEB) , ... January 24, 2017 , ... ... breast implants, a new scientific article suggests that autologous fat grafting—taking ... for achieving larger breasts naturally, without breast implants. , Cosmetic Surgeon and ...
(Date:1/24/2017)... IL (PRWEB) , ... January 23, 2017 , ... ... is partnering with Plug and Play, the world’s largest start-up platform headquartered in ... companies a year. , OSF Ventures recently signed a three-year agreement to ...
(Date:1/24/2017)... Texas (PRWEB) , ... January 23, 2017 , ... ... its presence in Texas with the acquisitions of two personal care service companies: ... in Texas City, Texas, effective January 1, 2017. , Well regarded in their ...
(Date:1/24/2017)... ... January 23, 2017 , ... Somnoware, ... plugin that allows sleep centers to automatically connect and initialize all their devices ... client browser plugin is quickly installed on first use and then monitors device ...
Breaking Medicine News(10 mins):
(Date:1/23/2017)... , Jan. 23, 2017  Allergan plc, (NYSE: ... continued support of the International Headache Academy (IHA). Designed to ... and research scientists, IHA offers a three-day, intensive overview on ... Allergan has been the sole sponsor since the inception of ... and iHEAD in Europe in 2014. ...
(Date:1/23/2017)... 23, 2017 Ahead of today,s trading session, ... they have fared at the close: Kite Pharma Inc. (NASDAQ: ... OVAS ), and Regeneron Pharmaceuticals Inc. (NASDAQ: REGN ... relative laggards on Friday, January 20 th , 2017, down on ... reports on these stocks now at: ...
(Date:1/23/2017)... SAN DIEGO , 23 janvier 2017  ResMed ... Winter Haven , Floride) ont annoncé aujourd,hui qu,ils se ... les litiges existants entre les parties. BMC et 3B ... de paiements de droits à ResMed, et ResMed effectuera ... à 3B pour clore le litige de Floride entre ...
Breaking Medicine Technology: